Recent review on selective histone deacetylase inhibitors in cancer therapy

Recent Prospectives of Anticancer Histone Deacetylase Inhibitors

Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents

Design, molecular docking, synthesis, and in vitro pharmacological evaluation of biomolecules-histone deacetylase inhibitors conjugates with carbohydrazide as a novel zinc-binding

Design ,Synthesis, Insilco Study and Biological Evaluation of New Coumarin-Oxadiazole Derivatives as Potent Histone Deacetylase Inhibitors

Indolin-2-one based scaffold for the development of multi- kinase inhibitor: Focus on sunitinib as an anticancer agent

Coumarin based-histone deactylace HADC inhibitors

Novel Mannich Bases Derived from 2-Substituted Benzimidazole and (Thio)Hydantoin Moieties as Potent Histone Deacetylase 6 (HDAC6) Inhibitors

Histone Deacetylase Inhibitors in Cancer